Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Vimentin Antibodies:
anti-Mouse (Murine) Vimentin Antibodies:
anti-Rat (Rattus) Vimentin Antibodies:
Go to our pre-filtered search.
Human Monoclonal Vimentin Primary Antibody for IHC (p) - ABIN1686956
Lorenzatti, Huang, Pal, Cabanillas, Kleer: CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. in Journal of cell science 2011
Show all 24 Pubmed References
Human Monoclonal Vimentin Primary Antibody for FACS, IHC (p) - ABIN1686955
Caceres, Peña, de Andres, Illera, Lopez, Woodward, Reuben, Illera: Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. in PLoS ONE 2015
Show all 32 Pubmed References
Human Polyclonal Vimentin Primary Antibody for FACS, IF (cc) - ABIN672786
Liu, Han, Wang, Feng: Down-regulation of Wnt10a affects odontogenesis and proliferation in mesenchymal cells. in Biochemical and biophysical research communications 2013
Show all 27 Pubmed References
Human Polyclonal Vimentin Primary Antibody for IHC (p), WB - ABIN3042344
Quan, Du, Hou, Wang, Zhang: Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma. in Oncology reports 2017
Show all 56 Pubmed References
Human Monoclonal Vimentin Primary Antibody for IHC (p), WB - ABIN3043673
Zhu, Liu, Li, Liu, Wang, Sun, Xiong, Jiang, Zheng, Hu: Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. in Carcinogenesis 2014
Show all 55 Pubmed References
Dog (Canine) Polyclonal Vimentin Primary Antibody for ICC, IF - ABIN152563
Johnstone, Mongroo, Rich, Schupp, Bowser, Delemos, Tobias, Liu, Hannigan, Rustgi: Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation. in Molecular and cellular biology 2008
Show all 18 Pubmed References
Human Monoclonal Vimentin Primary Antibody for ICC, FACS - ABIN335273
Brussee, Smit, Koopman, Wijga, Kerkhof, Corver, Vos, Gerritsen, Grobbee, Brunekreef, Merkus, de Jongste: Interrupter resistance and wheezing phenotypes at 4 years of age. in American journal of respiratory and critical care medicine 2004
Show all 7 Pubmed References
Human Monoclonal Vimentin Primary Antibody for ICC, FACS - ABIN335382
Osborn, Debus, Weber: Monoclonal antibodies specific for vimentin. in European journal of cell biology 1984
Show all 7 Pubmed References
Dog (Canine) Monoclonal Vimentin Primary Antibody for ICC, IHC (fro) - ABIN1042493
Ramaekers, Huysmans, Schaart, Moesker, Vooijs: Tissue distribution of keratin 7 as monitored by a monoclonal antibody. in Experimental cell research 1987
Show all 5 Pubmed References
Dog (Canine) Monoclonal Vimentin Primary Antibody for ICC, IHC (fro) - ABIN1042494
Pieper, Schaart, Krimpenfort, Henderik, Moshage, van de Kemp, Ramaekers, Berns, Bloemendal: Transgenic expression of the muscle-specific intermediate filament protein desmin in nonmuscle cells. in The Journal of cell biology 1989
Show all 5 Pubmed References
This study evaluated the expression pattern of vimentin in testes of mature Arabian stallions and correlated its distribution with grade of seminiferous tubule impairment as indicated by a Johnsen score.
Vimentin- like transcript was expressed in both chordocytes and chordoblasts, whereas the elastin (show ELN Antibodies)- like transcript was uniquely expressed in the chordoblasts lining the notochordal sheath.
The findings support a mechanism in which miR (show MLXIP Antibodies)-375 suppresses RUNX1 (show RUNX1 Antibodies) levels, resulting in reduced vimentin and L-plastin (show LCP1 Antibodies) expression. Knockdown of RUNX1 (show RUNX1 Antibodies), L-plastin (show LCP1 Antibodies), and vimentin resulted in significant reductions in cell invasion in vitro, indicating the functional significance of miR (show MLXIP Antibodies)-375 regulation of specific proteins involved in head and neck squamous cell carcinoma (HNSCC) invasion.
Vimentin expression was an adverse prognostic factor for DSS (show NR0B1 Antibodies) in TSCC patients, even after the adjustment for cell differentiation, pathological stage, and expression levels of Snail (show SNAI1 Antibodies), Twist, E-cadherin (show CDH1 Antibodies), and N-cadherin (show CDH2 Antibodies). Snail (show SNAI1 Antibodies), E-cadherin (show CDH1 Antibodies), N-cadherin (show CDH2 Antibodies), and Vimentin were associated with tumorigenesis and pathological outcomes
circulating anti-vimentin IgG autoantibody levels are much greater in idiopathic pulmonary fibrosis subjects than in normal controls
RhoA (show RHOA Antibodies)/ROCK and Raf-1 (show RAF1 Antibodies)/CK2 (show CSNK2A1 Antibodies) pathway are responsible for TNF-alpha (show TNF Antibodies)-mediated endothelial cytotoxicity via regulation of the vimentin cytoskeleton.
It was concluded that islet cell expression of vimentin indicates a degree of plasticity and dedifferentiation with potential loss of cellular identity in diabetes.
findings have identified a role for members of these signaling pathways in the regulation of EGF (show EGF Antibodies)-induced vimentin expression in the MDA-MB-468 breast cancer cell line
vimentin regulates the differentiation switch via modulation of K5/K14 (show KRT14 Antibodies) expression. Moreover, because there was a significant correlation between high vimentin-K14 (show KRT14 Antibodies) expression and recurrence/poor survival in oral cancer patients, vimentin-K14 (show KRT14 Antibodies) together may prove to be the novel markers for the prognostication of human oral cancer.
Data indicate that ellagic aicd (EA) down-regulates the expression of COX-2 (show COX2 Antibodies), NF-kappa B (show NFKB1 Antibodies), vimentin and up-regulates the expression of E-cadherin (show CDH1 Antibodies) in in pancreatic carcinom PANC-1 cells.
Bevacizumab treatment was also associated with structural protein abnormalities, with decreased GFAP (show GFAP Antibodies) and vimentin content and upregulated GFAP (show GFAP Antibodies) and vimentin mRNA expression.
Decreasing cell surface vimentin by small interfering RNA (siRNA) knockdown in HeLa and NIKS cells significantly increased human papillomavirus 16 infectious internalization, while overexpression of vimentin had the opposite effect identifying vimentin as a viral restriction factor.
Immunocytochemistry for Vimentin detection in nuclei of IVF (show SCN5A Antibodies) and NT bovine embryos
These results indicate that the inner mass differentiates dynamically in blastocysts, as reflected by the expression of vimentin; higher vimentin expression may reflect the higher developmental competence of embryos.
an intact vimentin intermediate filament network contributes to the maintenance of the chondrocyte phenotype
Knockdown of filamin A (show FLNA Antibodies) or vimentin in normal cells profoundly suppresses apical extrusion of the neighbouring transformed cells.
This study is the first to show that vimentin has an important role in tumor metastasis in vivo in the setting of pre-diabetes and endogenous hyperinsulinemia.
These findings identify two specific sites on vimentin that are phosphorylated by Cadmium.
both arthritis-susceptible and -resistant mice can generate cellular and humoral immunity to Vim.
vimentin knockout neurons were insensitive to the axonotrophic effects of Clostridium botulinum C3 exoenzyme
These findings suggest that Plk1 (show PLK1 Antibodies) regulates smooth muscle contraction by modulating vimentin phosphorylation at Ser (show SIGLEC1 Antibodies)-56.
findings thus show that the inability to produce GFAP (show GFAP Antibodies) and Vim affects normal retinal physiology and that the effect of IF deficiency on retinal cell survival differs, depending on the underlying pathologic condition
these findings identify a hereto-unappreciated role for serine-38 phosphorylated vimentin as an important determinant of myofibroblast sensitivity to Withaferin A.
Vimentin expression increased after traumatic brain injury and was positively correlated with edema and neurological impairments.
Annexin, lamin (show LMNA Antibodies), and vimentin were identified as universal dystrophic markers
Astrocytes deficient of GFAP (show GFAP Antibodies) and vimentin showed decreased Notch (show NOTCH1 Antibodies) signal sending competence and altered expression of Notch (show NOTCH1 Antibodies) signaling pathway-related genes
As the inner cell mass forms the epiblast, SSEA1 (show FUT4 Antibodies) is lost and VIMENTIN is lost and re-expressed.
These observations indicate that vimentin serves as a putative receptor for Japanese encephalitis virus in porcine kidney cells.
Interaction of nucleocapsid protein of transmissible gastroenteritis virus with host vimentin is required for virus infection.
protein(s) that associated with RPTPbeta (show PTPRZ1 Antibodies) in response to IGF-I (show IGF1 Antibodies) and IGFBP-2 (show IGFBP2 Antibodies) in vascular smooth muscle cells
This study demonstrates that maternal VIM, as a genomic protector, is crucial for nuclear reprogramming in porcine cloned embryos.
Vim expression in corneal epithelium is found in a cell population composed of highly motile cells.
This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract.
, vimentin 1
, class-III intermediate microfilament